Published in JAMA on September 11, 1996
Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug? CMAJ (1999) 3.26
Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial. JAMA (2008) 3.16
Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis (2003) 1.48
A computerized intervention to decrease the use of calcium channel blockers in hypertension. J Gen Intern Med (1997) 1.39
Methods underpinning national clinical guidelines for hypertension: describing the evidence shortfall. BMC Health Serv Res (2006) 1.01
Calcium channel blockers. The jury is still out on whether they cause heart attacks and suicide. BMJ (1998) 0.96
Comparison of intensive and low-dose atorvastatin therapy in the reduction of carotid intimal-medial thickness in patients with coronary heart disease. Heart (2007) 0.93
Hypertension and diabetic retinopathy--what's the story? Br J Ophthalmol (1999) 0.92
Effect of serum withdrawal on the contribution of L-type calcium channels (CaV1.2) to intracellular Ca2+ responses and chemotaxis in cultured human vascular smooth muscle cells. Br J Pharmacol (2005) 0.84
The effects of calcium channel blockers in the prevention of stroke in adults with hypertension: a meta-analysis of data from 273,543 participants in 31 randomized controlled trials. PLoS One (2013) 0.83
Review of nifedipine GITS in the treatment of high risk patients with coronary artery disease and hypertension. Vasc Health Risk Manag (2009) 0.83
Antibodies against oxidized low-density lipoprotein are associated with subclinical atherosclerosis in recent-onset rheumatoid arthritis. Clin Rheumatol (2010) 0.82
Anti-apolipoprotein A-1 antibodies and carotid intima-media thickness in Egyptian women with systemic lupus erythematosus. Clin Rheumatol (2014) 0.81
Randomized clinical trials of antihypertensive drugs: all that glitters is not gold. CMAJ (1998) 0.80
Influence of hypertension and smoking as the single vascular risk factors on the intima-media thickness. Eur J Epidemiol (2001) 0.79
Calcium channel blockers. Lessons learned from MIDAS and other clinical trials. JAMA (1996) 0.79
Effects of antihypertensive drugs on carotid intima-media thickness: Focus on angiotensin II receptor blockers. A review of randomized, controlled trials. Integr Blood Press Control (2009) 0.78
Pleiotropic effects of calcium channel blockers. Curr Hypertens Rep (2012) 0.77
Differential impacts of blood pressure and lipid lowering on regression of ventricular and arterial mass: the Stop Atherosclerosis in Native Diabetics Trial. Hypertension (2011) 0.77
Carotid Intima-media Thickness Measurements: Relations with Atherosclerosis, Risk of Cardiovascular Disease and Application in Randomized Controlled Trials. Chin Med J (Engl) (2016) 0.76
Advances in diabetes for the millennium: the heart and diabetes. MedGenMed (2004) 0.75
Dyslipidemia in rural areas of North China: prevalence, characteristics, and predictive value. Lipids Health Dis (2016) 0.75
Global cardiovascular risk assessment in the management of primary hypertension: the role of the kidney. Int J Hypertens (2013) 0.75
The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS) JAMA (1997) 0.75
The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS) JAMA (1997) 0.75
Randomised comparison of the effects of nicardipine and esmolol on coronary artery wall stress: implications for the risk of plaque rupture. Heart (2000) 0.75
The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS) JAMA (1997) 0.75
A novel approach to treatment of hypertension in diabetic patients - a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on blood pressure levels in patients with hypertension and associated diabetes mellitus type 2 - rationale and design [ISRCTN55725285]. Curr Control Trials Cardiovasc Med (2004) 0.75
Anti-inflammatoryactivity of calciumchannel blocker lercanidipine hydrochloride. J Pharmacol Pharmacother (2013) 0.75
Inferiority of calcium channel blockers to cheaper drugs. News item was inaccurate on at least two counts. BMJ (2001) 0.75
Discovery and Development of Calcium Channel Blockers. Front Pharmacol (2017) 0.75
Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (1999) 8.04
Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. N Engl J Med (1983) 6.00
Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke (1991) 4.21
The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant (2011) 3.69
Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group. Stroke (1992) 3.09
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation (2000) 2.94
Frequent Hemodialysis Network (FHN) randomized trials: study design. Kidney Int (2006) 2.85
Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int (2000) 2.72
Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation (2001) 2.41
Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation. Am J Kidney Dis (1996) 2.30
Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung Cancer. Br J Cancer (2000) 2.30
Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men. Eur Heart J (2002) 2.24
The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis (1993) 2.22
Analgesic use and chronic renal disease. N Engl J Med (1989) 2.12
Magnetic resonance imaging compared to echocardiography to assess left ventricular mass in the hypertensive patient. Am J Hypertens (1995) 2.09
Endogenous digitalis-like substance in plasma of volume-expanded dogs. Nature (1980) 2.02
Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study. Am J Med (1996) 1.99
Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad Sci U S A (1999) 1.95
Diabetes mellitus and hypertension. Hypertension (1992) 1.93
Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab (2001) 1.93
Cancer genetics clinics: target population and consultees' expectations. Eur J Cancer (1996) 1.88
Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation (1995) 1.83
Altered platelet calcium metabolism as an early predictor of increased peripheral vascular resistance and preeclampsia in urban black women. N Engl J Med (1990) 1.80
Predictive factors of histologic response to primary chemotherapy in osteosarcoma of the extremity: study of 272 patients preoperatively treated with high-dose methotrexate, doxorubicin, and cisplatin. J Clin Oncol (1998) 1.80
Diabetes mellitus: a disease of abnormal cellular calcium metabolism? Am J Med (1994) 1.74
Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells. J Biol Chem (2000) 1.70
The contribution of childhood obesity to adult carotid intima-media thickness: the Bogalusa Heart Study. Int J Obes (Lond) (2008) 1.66
Racial/ethnic analysis of selected intermediate outcomes for hemodialysis patients: results from the 1997 ESRD Core Indicators Project. Am J Kidney Dis (1999) 1.61
Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease. J Mol Cell Cardiol (1999) 1.61
Osteosarcoma of the limb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapy. J Bone Joint Surg Br (2002) 1.58
Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. J Clin Oncol (1997) 1.56
Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment. Am Heart J (1995) 1.51
Physicochemical and histological changes in the arterial wall of nonhuman primates during progression and regression of atherosclerosis. J Clin Invest (1984) 1.50
TGF-beta1 activates MAP kinase in human mesangial cells: a possible role in collagen expression. Kidney Int (1999) 1.49
CLCN5 mutation Ser244Leu is associated with X-linked renal failure without X-linked recessive hypophosphatemic rickets. Kidney Int (1998) 1.47
Clinical review 145: Pleiotropic effects of statins: lipid reduction and beyond. J Clin Endocrinol Metab (2002) 1.47
Parosteal osteosarcoma dedifferentiating into telangiectatic osteosarcoma: importance of lytic changes and fluid cavities at imaging. Skeletal Radiol (2009) 1.47
Plasma norepinephrine responses to posture and isometric exercise increase with age in the absence of obesity. J Gerontol (1983) 1.46
Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens (1998) 1.46
Ultrasonic-pathological comparison of the human arterial wall. Verification of intima-media thickness. Arterioscler Thromb (1993) 1.44
Endothelium-dependent relaxation in aorta of BB rat. Diabetes (1987) 1.44
Survival in high-grade osteosarcoma: improvement over 21 years at a single institution. Ann Oncol (2009) 1.44
Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II) Am J Cardiol (1995) 1.43
Histologically verified lung metastases in benign giant cell tumours--14 cases from a single institution. Int Orthop (2006) 1.43
The relation of obesity throughout life to carotid intima-media thickness in adulthood: the Bogalusa Heart Study. Int J Obes Relat Metab Disord (2004) 1.41
Sex- and age-related antihypertensive effects of amlodipine. The Amlodipine Cardiovascular Community Trial Study Group. Am J Cardiol (1996) 1.41
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study. Ann Oncol (2011) 1.40
Fatal anaphylaxis in systemic mastocytosis. J Clin Pathol (1979) 1.39
Reactive hyperemia in patients with Raynaud's phenomenon. J Rheumatol (1988) 1.39
The human carotid atherosclerotic plaque stimulates angiogenesis on the chick chorioallantoic membrane. Atherosclerosis (1992) 1.39
The health care needs of southeast asian refugees. Can Fam Physician (1988) 1.38
Nifedipine GITS (gastrointestinal therapeutic system) bezoar. Arch Intern Med (1991) 1.38
Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation. Arch Intern Med (1989) 1.37
Association of coronary disease with segment-specific intimal-medial thickening of the extracranial carotid artery. Circulation (1995) 1.36
A comparison of the efficacy and safety of a beta-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Intern Med (1990) 1.35
Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol. Eur J Cancer (2001) 1.34
Anatomic correlates of aortic pulse wave velocity and carotid artery elasticity during atherosclerosis progression and regression in monkeys. Circulation (1991) 1.33
The effect of dialysates and ultrafiltrates of plasma of saline-loaded dogs on toad bladder sodium transport. J Clin Invest (1970) 1.33
Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin. Cancer Res (1996) 1.33
Preclinical characterization of the potential of the putative atypical antipsychotic MDL 100,907 as a potent 5-HT2A antagonist with a favorable CNS safety profile. J Pharmacol Exp Ther (1996) 1.32
Inhibition of insulin-like growth factor I receptor increases the antitumor activity of doxorubicin and vincristine against Ewing's sarcoma cells. Clin Cancer Res (2001) 1.29
Correlates of carotid artery stiffness in young adults: The Bogalusa Heart Study. Atherosclerosis (2004) 1.28
Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group. Clin Cardiol (2000) 1.27
Antihypertensive therapy and the risk of type 2 diabetes mellitus. N Engl J Med (2000) 1.27
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol. Ann Oncol (2010) 1.25
Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute. Ann Oncol (2001) 1.25
Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone: a preliminary report of 6 years of experience. Cancer (1999) 1.24
Sonographic evaluation of carotid artery atherosclerosis in the elderly: relationship of disease severity to stroke and transient ischemic attack. Radiology (1993) 1.23
Leukocyte count correlates in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol (1992) 1.21
Associations of risk factors with segment-specific intimal-medial thickness of the extracranial carotid artery. Stroke (1999) 1.20
Financial cost as an obstacle to hypertension therapy. Am J Public Health (1986) 1.20
Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb (1994) 1.19
Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities. J Clin Oncol (1993) 1.19
Systolic Hypertension in the Elderly Program (SHEP): antihypertensive efficacy of chlorthalidone. Am J Cardiol (1985) 1.19
Monotherapy with labetalol compared with propranolol. Differential effects by race. J Clin Hypertens (1985) 1.18
Metoclopramide stimulates prolactin secretion in man. J Clin Endocrinol Metab (1976) 1.18
Osteosarcoma. Low-grade intraosseous-type osteosarcoma, histologically resembling parosteal osteosarcoma, fibrous dysplasia, and desmoplastic fibroma. Cancer (1993) 1.18
Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men. Circulation (1999) 1.18
Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study. Stroke (1989) 1.17
Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy. Acta Orthop Scand (1998) 1.16
Use of pentoxifylline as an inhibitor of free radical generation in peripheral vascular disease. Results of a double-blind placebo-controlled study. Eur J Clin Pharmacol (1991) 1.16
Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B). J Cell Physiol (1993) 1.16
Surgical treatment and outcome of conventional pelvic chondrosarcoma. J Bone Joint Surg Br (2005) 1.16
17 beta-Estradiol attenuates voltage-dependent Ca2+ currents in A7r5 vascular smooth muscle cell line. Am J Physiol (1994) 1.16
Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy. Ann Oncol (1997) 1.16
Immunohistochemical localization of heat shock protein-70 in normal-appearing and atherosclerotic specimens of human arteries. Am J Pathol (1990) 1.16
Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation (1996) 1.16
The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells. Kidney Int (1999) 1.15
Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease. J Am Coll Cardiol (1990) 1.15
Modular prosthetic replacement of the proximal femur after resection of a bone tumour a long-term follow-up. J Bone Joint Surg Br (2001) 1.13
Shear stress enhances human endothelial cell wound closure in vitro. Am J Physiol Heart Circ Physiol (2000) 1.13
Massive bone allograft reconstruction in high-grade osteosarcoma. Clin Orthop Relat Res (2000) 1.13
The syndrome of distal (type 1) renal tubular acidosis. Clinical and laboratory findings in 58 cases. Medicine (Baltimore) (1988) 1.12
Arterial abnormalities in the offspring of patients with premature myocardial infarction. N Engl J Med (2000) 1.12
Endothelium-dependent relaxation in experimental atherosclerosis in the rabbit. Circ Res (1987) 1.12